# KEVZARA

NDC: 0024-5922
Generic name: sarilumab
Labeler / Manufacturer: Sanofi-Aventis U.S. LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20170522

FDA application: BLA761037

## Active ingredients

- SARILUMAB: 200 mg/1.14mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0024-5922"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0024-5922
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=827bc01c-d379-4266-a18c-c7f904b76af3